Momo Vuyisich

Founder and Chief Science Officer at Viome

Momo Vuyisich is a founder and Chief Science Officer of Viome. He is also an Adjunct Professor at the University of New Mexico and New Mexico Tech. Besides providing scientific leadership at Viome, Momo focuses on product development, clinical certification, and clinical research.

Before co-founding Viome in 2016, Momo spent 12 years at Los Alamos National Laboratory, where he was the leader of the Applied Genomics team. His research focused on applying modern genomics to the areas of gut microbiomes, host-pathogen and microbial inter-species interactions, pathogen detection, cancer biology, toxicology, infectious diseases, antibiotic resistance, forensics, etc. He also helped set up several genome centers in Africa and Asia.

Momo received his PhD in Biochemistry from the University of Utah, and BS in Microbiology from the University of Texas at El Paso.

Momo_Vuyisich_BioTech_Pharma_Summit_Viome_Skin_Microbiome_Gut_Week_BioTech_Pharma_Summit_Brain_1

Case Study: Platform that allows to study the connections among diet, gut microbiome, immune system, human physiology, and health/disease states

  • Our clinically-validated stool metatranscriptomic test enables us to identify the biochemical output of the gut microbiome that is associated with a disease.
  • Our translational science and AI teams are then able to design personalized diets to adjust the biochemical output and (hopefully) reverse chronic diseases.
  • Describe this discovery platform and show our progress towards obesity, depression, IBS, diabetes (these 4 chronic diseases have >50% prevalence in the human population)
  • Offer the platform as a collaborative tool between clinicians and Viome, towards preventing/reversing all chronic diseases

Other Speakers from the Gut Week Summit

Éile Butler

Scientific officer, Business Development at BioGaia

Huiying Li

Associate Professor at University of California, Los Angeles

Larry Weiss

Chief Executive Officer and Founder at Persona Biome